Saboo Sodium

When is the next results date for Saboo Sodium?

No Upcoming Board Meetings

Who are in the management team of Saboo Sodium?

As of March 2022, the management team of Saboo Sodium includes Girdhar Saboo (Managing Director), Sangita Devi, Nagendra Singh, Madan Singh Jain, Kamal Bhardwaj (Whole-time Director), Ramavtar Sharma (Company Secretary), Kamal Sharma, and Gopal Kumawat (Additional Director), with varying remuneration for each role.

As of March 2022, the management team of Saboo Sodium includes the following individuals:<BR><BR>1. Girdhar Saboo - Managing Director, with a remuneration of Rs. 48.0 lacs.<BR>2. Sangita Devi - Director, with no remuneration.<BR>3. Nagendra Singh - Independent Director, with no remuneration.<BR>4. Madan Singh Jain - Independent Director, with no remuneration.<BR>5. Kamal Bhardwaj - Whole-time Director, with a remuneration of Rs. 1.4 lacs.<BR>6. Ramavtar Sharma - Company Secretary & Compliance Officer, with no remuneration.<BR>7. Kamal Sharma - Independent Director, with no remuneration.<BR>8. Gopal Kumawat - Additional Director, with no remuneration.<BR><BR>This team comprises a mix of managing, independent, and additional directors, along with a compliance officer.

What does Saboo Sodium do?

Saboo Sodium Chloro Ltd is the largest salt refinery in North India, operating in the FMCG sector as a micro-cap company. As of March 2025, it reported net sales of 13 Cr and a net loss of 4 Cr, with a market cap of Rs 74 Cr.

Overview:<BR>Saboo Sodium Chloro Ltd is the largest salt refinery in North India, operating within the FMCG industry and classified as a micro-cap company.<BR><BR>History:<BR>The company was incorporated on November 22, 1993, and has been engaged in salt manufacturing since its inception. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 13 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: -4 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 74 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 75.00<BR>- Industry P/E: 54<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.38<BR>- Return on Equity: 0.36%<BR>- Price to Book: 1.60<BR><BR>Contact Details:<BR>Address: L-5 B-11 Krishna Marg, C-Scheme Surya House Jaipur Rajasthan : 302001 <BR>Tel: 91-0141-2379483/2375451/4053000 <BR>Email: salt@suryasalt.com <BR>Website: http://www.suryasalt.com

Has Saboo Sodium declared dividend?

No Dividend History Available

Who are the peers of the Saboo Sodium?

Saboo Sodium's peers include Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Vistar Amar, Jhandewala Foods, Dindigul Farm, and Simran Farms, with varying management risks and returns, where Saboo Sodium has below average management risk and a 1-year return of 5.90%.

Peers: The peers of Saboo Sodium are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Vistar Amar, Jhandewala Foods, Dindigul Farm, and Simran Farms.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, and Britannia Inds., while Good management risk is found at Hind. Unilever, Godrej Consumer, Dindigul Farm, and Simran Farms. Average management risk is noted at Vistar Amar, and Saboo Sodium has Below Average management risk. Growth is Excellent at Dindigul Farm, Average at Nestle India, and Below Average at Hind. Unilever, ITC, Britannia Inds., Godrej Consumer, Vistar Amar, Saboo Sodium, and Simran Farms, while Jhandewala Foods does not qualify. Capital Structure is Excellent at Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, and Vistar Amar, while Saboo Sodium has Below Average capital structure, and Dindigul Farm has Below Average capital structure, with Jhandewala Foods not qualifying.<BR><BR>Return Snapshot: Britannia Inds. has the highest 1-year return at 7.76%, while Jhandewala Foods has the lowest at -66.20%. Saboo Sodium's 1-year return is 5.90%, which is higher than Jhandewala Foods but lower than Britannia Inds. Additionally, the six-month returns are negative for Hind. Unilever, ITC, Godrej Consumer, Vistar Amar, Dindigul Farm, and Simran Farms.

What is the technical trend for Saboo Sodium?

As of June 2, 2025, Saboo Sodium's technical trend has shifted to a bearish stance, supported by bearish daily moving averages and Bollinger Bands, while showing mixed signals in the MACD and KST across different time frames.

As of 2 June 2025, the technical trend for Saboo Sodium has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. Key indicators driving this stance include the daily moving averages which are bearish, and the Bollinger Bands indicating bearish conditions on both weekly and monthly time frames. The MACD shows a mildly bullish signal on the weekly but is mildly bearish on the monthly, suggesting a potential divergence in short-term versus long-term trends. The KST aligns with this by being mildly bullish weekly but mildly bearish monthly. Overall, the bearish trend is reinforced by the Dow Theory indicating a mildly bearish stance on the weekly chart.

Who are the top shareholders of the Saboo Sodium?

The top shareholder of Saboo Sodium is Girdhar Saboo, holding 45.6% of the shares, while individual investors own 43.41%. There are no institutional or foreign investors, and mutual funds hold only 0.08%.

The top shareholders of Saboo Sodium include Girdhar Saboo, who is the promoter with the highest holding at 45.6%. Additionally, individual investors collectively hold 43.41% of the company's shares. There are no institutional investors or foreign institutional investors holding shares in the company, and mutual funds hold a minimal percentage through five schemes, accounting for 0.08%. There are no pledged promoter holdings or significant public shareholders noted.

How big is Saboo Sodium?

As of 24th July, Saboo Sodium Chloro Ltd has a market capitalization of 69.00 Cr, with recent net sales of 55.03 Cr and a net profit of 0.17 Cr. The balance sheet for March 2024 shows shareholder's funds of 46.56 Cr and total assets of 69.78 Cr.

As of 24th July, Saboo Sodium Chloro Ltd has a market capitalization of 69.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 55.03 Cr and a Net Profit of 0.17 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 46.56 Cr and Total Assets of 69.78 Cr.

How has been the historical performance of Saboo Sodium?

Saboo Sodium's historical performance shows fluctuating net sales, increasing from 49.36 Cr in Mar'23 to 55.02 Cr in Mar'25, but lower than the peak of 79.28 Cr in Mar'22. While profit after tax improved to 0.31 Cr, the company faces challenges with rising costs and negative cash flow of -12.00 Cr in Mar'25.

Answer:<BR>The historical performance of Saboo Sodium shows a fluctuating trend in net sales and profitability over the years. <BR><BR>Breakdown:<BR>Saboo Sodium's net sales have increased from 49.36 Cr in Mar'23 to 55.02 Cr in Mar'25, although they peaked at 79.28 Cr in Mar'22. The total operating income followed a similar pattern, rising to 55.02 Cr in Mar'25 from 49.36 Cr in Mar'23, but again lower than the 79.28 Cr recorded in Mar'22. The company's total expenditure, excluding depreciation, was 50.77 Cr in Mar'25, up from 46.00 Cr in Mar'23, indicating rising costs. Operating profit (PBDIT) increased to 4.42 Cr in Mar'25 from 3.97 Cr in Mar'23, with a slight improvement in the operating profit margin to 7.72%. Profit before tax saw a decline to 0.17 Cr in Mar'25 from 0.26 Cr in Mar'23, while profit after tax improved to 0.31 Cr from 0.18 Cr in the same period. The company's total assets rose to 74.56 Cr in Mar'25 from 68.84 Cr in Mar'23, with total liabilities also increasing to 74.56 Cr. Cash flow from operating activities turned negative at -12.00 Cr in Mar'25, contrasting with a positive cash flow of 5.00 Cr in Mar'24. Overall, while Saboo Sodium has shown growth in sales and profit after tax, it faces challenges with rising costs and cash flow management.

Is Saboo Sodium overvalued or undervalued?

As of November 19, 2025, Saboo Sodium is considered very attractive and undervalued compared to peers like Hindustan Unilever and Nestle India, with a PE ratio of 88.61 and an EV to EBITDA of 17.96, despite a year-to-date stock performance lagging at -42.42% against the Sensex's 9.02%.

As of 19 November 2025, the valuation grade for Saboo Sodium has moved from attractive to very attractive, indicating a significant positive shift in its perceived value. The company is currently assessed as undervalued, particularly when compared to its peers. Key ratios include a PE ratio of 88.61, an EV to EBITDA of 17.96, and a ROCE of 4.13%. <BR><BR>In comparison to notable peers, Hindustan Unilever has a PE ratio of 54.22 and an EV to EBITDA of 38.41, while Nestle India shows a PE of 82.44 and an EV to EBITDA of 51.14. These comparisons highlight Saboo Sodium's relatively lower valuation metrics despite its strong grade. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -42.42% compared to the Sensex's 9.02%, reinforcing the undervaluation narrative.

Are Saboo Sodium Chloro Ltd latest results good or bad?

Saboo Sodium Chloro Ltd's latest results are concerning, showing a 63.53% decline in net profit despite an 11.33% revenue increase, indicating significant margin compression and operational challenges. Overall, the results lean more negative than positive.

The latest results for Saboo Sodium Chloro Ltd present a mixed picture, leaning towards the negative side. In Q3 FY26, the company reported a net profit of ₹0.85 crore, which is a significant decline of 63.53% compared to the previous quarter. This sharp drop in profit is concerning, especially given that revenue increased by 11.33% to ₹17.19 crore, marking the highest quarterly sales in the company's history.<BR><BR>However, the operating margin saw a drastic reduction from 21.31% to just 10.47%, indicating severe margin compression. This suggests that while the company is generating more sales, it is struggling to convert that revenue into profit effectively, likely due to rising input costs or operational inefficiencies.<BR><BR>Over the nine-month period of FY26, the company experienced a slight decline in cumulative net profit compared to the previous year, despite a 16.42% increase in net sales. This reflects ongoing challenges in maintaining profitability amid rising costs.<BR><BR>Overall, while the revenue growth is a positive sign, the significant drop in net profit and operating margins raises serious concerns about the company's financial health and operational efficiency. Therefore, the latest results can be viewed as more negative than positive, highlighting critical issues that need to be addressed.

Should I buy, sell or hold Saboo Sodium Chloro Ltd?

Which are the latest news on Saboo Sodium?

Why is Saboo Sodium Chloro Ltd falling/rising?

As of 11-Apr, the stock price of Saboo Sodium Chloro Ltd is declining at 12.26, down 0.73%. The stock has underperformed significantly over the past year and three years, with weak fundamentals and decreased investor participation contributing to its unattractiveness as an investment.

As of 11-Apr, the stock price of Saboo Sodium Chloro Ltd is falling, currently at 12.26, reflecting a change of -0.09 or -0.73%. This decline can be attributed to several factors highlighted in the data. Over the past year, the stock has generated a return of -31.05%, significantly underperforming the benchmark Sensex, which has gained 5.01% during the same period. Additionally, the stock has shown a consistent underperformance against the benchmark over the last three years, with a -29.46% return compared to the Sensex's +29.58%.<BR><BR>Investor participation has also decreased, as indicated by a 41.57% drop in delivery volume compared to the five-day average. Although the stock is trading above its 5-day and 20-day moving averages, it remains below the 50-day, 100-day, and 200-day moving averages, suggesting a lack of upward momentum. Furthermore, the company's long-term fundamentals are weak, with a -1.60% CAGR growth in operating profits over the last five years and a poor EBIT to interest ratio of 1.06, indicating challenges in servicing its debt.<BR><BR>Despite some positive results, such as a higher PAT and net sales, the overall financial health of the company is concerning, with profits having fallen by 95.4% over the past year. This combination of factors contributes to the stock's decline, making it a less attractive investment option at this time.